Package leaflet: Information for the patient

VASMINA 500 mg film-coated tablets

Micronized flavonoids, as diosmin and other flavonoids expressed as hesperidin
Please read this leaflet carefully before taking this medicine because it contains important information for you.
Always take this medicine exactly as described in this leaflet or as your doctor or pharmacist has told you to do.

Keep this leaflet. You may need to read it again.
If you need more information or advice, consult your pharmacist.
If you experience any side effects, including those not listed in this leaflet, contact your doctor or pharmacist. See section 4.
Contact your doctor if you do not notice any improvement or if you experience worsening of symptoms after 7 days.

Contents of this leaflet:

What VASMINA is and what it is used for
What you need to know before taking VASMINA
How to take VASMINA
Possible side effects
How to store VASMINA
Contents of the pack and other information

1. What VASMINA is and what it is used for

VASMINA is a vasoprotective agent: it increases venous tone and the resistance of small blood vessels.
VASMINA is indicated in adults for the treatment of:

symptoms related to chronic venous insufficiency of the lower limbs: heaviness, swelling, pain or cramps in the legs;
capillary fragility (easy rupture of capillaries, which become visible on the skin and may cause spots and bruising);
functional symptoms associated with acute hemorrhoidal crisis, such as pain, bleeding, and swelling in the anal region.
Consult your doctor if you do not feel better or if you feel worse after one week of treatment.

2. What you should know before taking VASMINA

Do not take VASMINA
If you are allergic to the active substances or to any of the other ingredients of this medicine (listed in
section 6).

Warnings and precautions
Talk to your doctor or pharmacist before taking VASMINA.

Chronic venous disease
If your condition worsens during treatment, with symptoms such as inflammation of the skin or veins, hardening of the subcutaneous tissue, severe pain, skin ulcers, or atypical symptoms such as sudden swelling of one or both legs, speak to your doctor immediately.
VASMINA does not help reduce swelling of the lower limbs if this is caused by heart, kidney, or liver diseases.
1 / 4
In case of venous insufficiency, treatment should be combined with a healthy lifestyle to achieve the best results. Avoid exposure to sunlight and heat, prolonged standing, and being overweight.
Walking and wearing special compression stockings improve circulation.

Acute haemorrhoidal disease
If you have an acute haemorrhoid attack, you may take VASMINA only for a limited period of 7 days. If symptoms of acute haemorrhoidal crisis do not disappear within 7 days, speak to your doctor.
If your condition worsens during treatment—for example, if you notice increased rectal bleeding, blood in the stool, or have doubts about haemorrhoidal bleeding—consult your doctor immediately.
Treatment with VASMINA does not replace specific treatment for other anal disorders.
If you have any questions, ask your doctor or pharmacist.

Children and adolescents
The use of VASMINA is not recommended in children and adolescents.

Other medicines and VASMINA
Inform your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
Currently, no interactions with other medicines are known.

Pregnancy and breastfeeding
If you are pregnant, suspect you may be pregnant, planning a pregnancy, or are breastfeeding, ask your doctor or pharmacist for advice before taking this medicine.
This medicine is not recommended during pregnancy and breastfeeding due to the lack of clinical data.

Driving and using machines
This medicine does not affect or affects negligibly the ability to drive vehicles or operate machinery.

VASMINA contains sodium
This medicine contains less than 1 mmol (23 mg) of sodium per dose, i.e. essentially "sodium-free".

3. How to take VASMINA

Take this medicine exactly as stated in this leaflet or as instructed by your doctor or pharmacist. If you have any doubts, consult your doctor or pharmacist.

Chronic venous insufficiency
The recommended dose for adults is 2 tablets daily, taken with the main meals (lunch and dinner), including in cases of haemorrhoids.
Do not exceed the maximum daily dose.
Treatment may last up to 8 weeks. Contact your doctor if you do not feel better or if you feel worse; the doctor will assess whether treatment should continue.

Acute haemorrhoidal attack
During the first 4 days of treatment, the recommended dose for adults is 3 tablets twice daily (6 tablets per day). During the following 3 days, the dose is 2 tablets twice daily (4 tablets per day).
Do not exceed the maximum daily dose.
Take these tablets with meals.

If you are taking VASMINA to treat symptoms of acute haemorrhoidal disease, consult your doctor or pharmacist if you do not feel better or if you feel worse after 7 days.

If you take more VASMINA than you should
If you have taken more VASMINA than you should, contact your doctor or pharmacist.
Experience with overdose of micronized flavonoids is limited. Possible adverse effects in case of overdose may include diarrhoea, nausea, abdominal pain, pruritus, and skin rash.

If you forget to take VASMINA
Do not take a double dose to make up for the missed dose.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everyone gets them.
The side effects, which may occur with the frequencies described below, include:
Common (may affect up to 1 in 10 people)
Nausea, vomiting, diarrhoea, indigestion (dyspepsia).
Uncommon (may affect up to 1 in 100 people)
Inflammation of the colon (colitis).
Rare (may affect up to 1 in 1,000 people)
Headache, dizziness, malaise, skin rash, itching, urticaria.
Not known (frequency cannot be estimated from the available data)
Abdominal pain, abnormally low platelet count (thrombocytopenia), swelling of the face, lips or eyelids (edema) associated with allergic symptoms. In rare cases, rapidly developing swelling of the face, lips, mouth, tongue or pharynx may occur, possibly accompanied by breathing difficulties (angioedema/Quincke's edema).

Reporting of side effects
If you experience any side effect, including those not listed in this leaflet, talk to your doctor or pharmacist. You can also report side effects directly via the national reporting system at https://www.aifa.gov.it/content/segnalazioni-reazioni-avverse.
By reporting side effects, you can help provide more information on the safety of this medicine.

5. How to store VASMINA

Keep this medicine out of the sight and reach of children.
OPA/AL/PVC blister packs: This medicine does not require any special storage conditions.
PVC/AL blister packs: Store at a temperature not exceeding 25°C.
Do not use this medicine after the expiry date stated on the packaging after "Exp". The expiry date refers to the last day of that month.
Do not dispose of medicines via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer in use. This will help protect the environment.

6. Package contents and other information

What VASMINA contains
3 / 4
The active substance consists of micronized flavonoids, namely diosmin and other flavonoids expressed as hesperidin. Each film-coated tablet contains 500 mg of micronized flavonoids, including 450 mg of diosmin and 50 mg of other flavonoids expressed as hesperidin.
The other components are:
Tablet core: gelatin, sodium lauryl sulfate, sodium starch glycolate (type A), microcrystalline cellulose, magnesium stearate, talc.
Coating: hypromellose (E464), titanium dioxide (E171), glycerol (E422), magnesium stearate (E470b), yellow iron oxide (E172), red iron oxide (E172), macrogol (E1521).
Description of the appearance of VASMINA and pack sizes
VASMINA is presented in a cardboard box containing blisters made of OPA/AL/PVC or PVC/AL with 30, 60 or 120 film-coated tablets, salmon-red in colour and oblong in shape.
Not all pack sizes may be marketed.
Marketing Authorization Holder
Pharmeg S.r.l. - Via dei Giardini, 34 – 85033 Episcopia (PZ), Italy
Manufacturer
Doppel Farmaceutici S.r.l. – Via Volturno, 48 – 20089 Quinto De’ Stampi - Rozzano (MI), Italy
4 / 4